Missouri Tech & Science

SEC and SiriusXM to Launch Exclusive New Sports Channel - SiriusXM SEC Radio

30 11 2017

NEW YORK, Nov. 30, 2017 -- The Southeastern Conference (SEC) and SiriusXM announced today that they will launch SiriusXM SEC Radio, a new and exclusive 24/7 audio channel dedicated to SEC sports that will deliver fans and alumni across the country in-depth and comprehensive access to SEC-focused sports talk and news, plus an extensive schedule of SEC games. SEC and SiriusXM to Launch Exclusive New Sports Channel – SiriusXM SEC Radio SiriusXM SEC Radio will launch early next year and will be available exclusively to SiriusXM subscribers via the SiriusXM app, on connected devices including smart TVs, Amazon Alexa devices, Sony PlayStation, Roku and more, and on select SiriusXM satellite radios (channel 374). The new channel's programming lineup will include exclusive new shows as well as simulcasts of SEC Network programming, and will give listeners access to weekly college coaches shows, press conferences, classic SEC game broadcasts, coverage of SEC Media...

Vaccinex and Catalent Biologics to Collaborate on Antibody-Drug Conjugate Development

30 11 2017

Vaccinex is excited to partner with Catalent Biologics to develop this novel antibody-drug conjugate for the treatment of cancer. We feel that by combining an ActivMAb antibody with Catalent’s SMARTag conjugation technology, we can generate a unique, differentiated molecule. SOMERSET, N.J. and ROCHESTER, N.Y. November 30, 2017 Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and Vaccinex, Inc., a clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies and other targeted biological therapies, today announced an agreement to develop an antibody-drug conjugate (ADC) using Catalent’s proprietary SMARTag® conjugation platform and GPEx® cell line engineering technologies, and Vaccinex’s proprietary ActivMAb® technology. The collaboration will focus on developing the ADC against an undisclosed cancer...

New Partnerships to Strengthen Innovation and Entrepreneurship at uCity Square

30 11 2017

Now, we’re taking business incubation to the next level as we shift our focus away from operating physical spaces for startups and reinvest our efforts into the people and ideas that make up those companies - the innovators and innovations who are changing our collective future. PHILADELPHIA, PA November 30, 2017 The University City Science Center, CIC and Venture Café announced further details about their partnership to catalyze and accelerate innovation and entrepreneurship in Greater Philadelphia on Wednesday, November 29, 2017 at a reception at uCity Square. When 3675 Market Street opens in 2018, it will be the new home for the Science Center’s headquarters, an expanded Quorum and FirstHand Lab – and the first Philadelphia location for anchor tenant CIC, a globally recognized company that combines world-class office and lab facilities with intense, productive innovation communities. CIC will manage the shared lab and office facilities in the new building. The Science Center...

Industry Veteran Dr. Maqsood Rehman Promoted to Chief Executive Officer of Gala Global Inc.; Company Strengthens Senior Management Team as it Repositions Company’s Growth Strategy

30 11 2017

ANAHEIM, Calif., Nov. 30, 2017 -- Gala Global, Inc. (OTC Pink:GLAG) today announced that it has promoted Dr. Maqsood Rehman, to the Chief Executive Officer of Gala Global, Inc., taking over from Timothy Madden, along with Joseph Earle as COO.  Dr. Rehman will be taking over the position from Timothy Madden, who has assumed the responsibilities as the CEO of Controlled Environment Genomics, Inc., (CEG), a subsidiary of Gala Global Inc.  Dr. Rehman holds a Masters degree and PhD degree in Plant Science from the University of Idaho as well as a Post Doctorate degree from the University of Missouri-Columbia.Dr. Rehman has a diversified scientific background with training with over ten years of industry experience in plant breeding, quantitative and molecular genetics, cytogenetics and project management.“Today’s senior management changes will represent the first of many stages of what will emerge as a new company that has clearly identified its target markets, geographic expansion...

Lockheed Martin Autonomous Driving System Tops 55,000 Miles in Extended Army Testing

29 11 2017

DALLAS, Nov. 29, 2017 -- Lockheed Martin's (NYSE: LMT) Autonomous Mobility Applique System (AMAS) logged more than 55,000 testing miles during the U.S. Army Extended Warfighter Experiment (EWE) at Fort Leonard Wood, Missouri, and Fort Bliss, Texas. U.S. Army trucks equipped with Lockheed Martin's AMAS technology undergo an autonomous driving test at Fort Hood, Texas, in 2014. "The testing was conducted by Soldiers and Lockheed Martin personnel over several months at two major military installations in a variety of mission scenarios," said Kathryn Hasse, Combat Manuever Systems director at Lockheed Martin Missiles and Fire Control. "Soldiers operating the AMAS vehicles provided us very positive feedback about how the system freed them up to do the job of a Soldier instead of the job of a truck driver." AMAS is an applique kit comprising sensors, actuators and controls that can be installed on virtually any military tactical wheeled vehicle. AMAS provides driver...

SmithFoods Company Adopts ReposiTrak® Food Safety Compliance Management Solution

29 11 2017

SALT LAKE CITY, Nov. 29, 2017 -- Park City Group’s (NASDAQ:PCYG) ReposiTrak, Inc., the leading provider of Compliance Management and Track & Trace solutions for the grocery and foodservice industries, announces today SmithFoods is adopting ReposiTrak’s Compliance Management System to manage their growing list of document requirements under the Food Safety Modernization Act (FSMA). SmithFoods is a provider of fresh, wholesome quality dairy and plant-based products for co-manufacturing, foodservice and private label opportunities, and also sells products under its SMITH’S, Ruggles, Artisa and Ajoyo brands. The company operates facilities in Orrville, Ohio; Richmond, Indiana and Pacific, Missouri, and is a member of the national Quality Chekd (QCS) organization, a not-for-profit, member-owned cooperative that delivers purchasing solutions through aggregate buying power. SmithFoods is the sixth QCS member to adopt ReposiTrak’s Compliance Management System.“We had been looking...

Advanced TeleHealth Solutions Named 1 of 10 Most Promising Telemedicine Solution Providers

29 11 2017

    SPRINGFIELD, MO, November 29, 2017 -- Advanced TeleHealth Solutions has been named one of the 10 companies at the leading edge of telemedicine, the company announced. CIOReview, which annually ranks the top 10 companies at the forefront of providing telemedicine solutions, published its 2017 list in its October 31 edition."To help CIOs, CFOs, and CEOs find the right solutions for their telemedicine initiatives," the magazine wrote, "a distinguished panel comprising CEOs, CFOs, analysts, and CIOReview's editorial board has selected the top players in the sector. The companies featured here demonstrate an ability to develop innovative technologies and methodologies while providing outstanding customer service and serve as benefactors of healthcare society."Advanced TeleHealth Solutions, which is one the nation's leading and most-progressive telehealth companies, was selected for the list largely because of its integrated suite of products and services that...

EIT Emerging Implant Technologies Announces First Cases Completed Successfully by Top Surgeons in the United States

28 11 2017

We are thrilled to be working with these thought-leading surgeons since our initial product launch at NASS. The market response and adoption exceeds our expectations by far. --Guntmar Eisen, CEO ROSWELL, Ga. November 28, 2017 Emerging Implant Technologies GmbH (EIT), a German medical device manufacturer exclusively focused on creating innovative technologies for spinal application by utilizing additive manufacturing, announces that it has now performed the first surgeries in the United States and is able to offer all interbody products for Cervical, ALIF, TLIF and PLIF procedures. EIT Cellular Titanium® is a 3D printed porous titanium structure that has been designed according to scientific insights on ideal pore shape and size to optimize cell proliferation and bone ingrowth. The first surgeons to implant this novel cage technology were: Matthew Gornet, orthopaedic spine surgeon at St. Louis Spine and Orthopedic Surgery Center Gurvinder Deol, orthopaedic spine surgeon at Wake...

Support of Student Privacy and Security of Student Data Leads Raytown Quality Schools to Select itslearning as its LMS Platform

28 11 2017

We are responsible for safeguarding our student’s data privacy in a digital terrain, and we needed the framework that itslearning readily offers to not only assure but demonstrate to parents that we are committed to protecting student data. BOSTON November 28, 2017 Raytown Quality Schools, one of just seven districts in the nation to receive the Consortium for School Networking (COSN) Trusted Learning Environment Seal, has chosen itslearning as its new learning management system (LMS) after a rigorous search for a partner that could support the district’s commitment to student data privacy. The state of Missouri had originally moved forward with another LMS for a state-wide contract. However, Raytown Director of Instructional Technology Melissa Tabbenkamp, CETL, realized that the other provider didn’t meet the Trusted Learning Environment standards. So she searched for a different LMS, one that would support her district’s commitment to this 21st century educational challenge...

Vir Biotechnology Appoints Herbert W. “Skip” Virgin Executive Vice President and Chief Scientific Officer

28 11 2017

SAN FRANCISCO--Vir Biotechnology, Inc. today announced the appointment of Herbert W. "Skip" Virgin, M.D., Ph.D., as Executive Vice President of Research and Chief Scientific Officer, effective January 1, 2018. Reporting to CEO George Scangos and joining Vir’s management team, Dr. Virgin will lead the company’s significant and growing internal R&D programs to transform the care of people with serious infectious diseases. Dr. Virgin will join Vir from Washington University School of Medicine, St. Louis, Missouri, where he has served as the Edward Mallinckrodt Professor and Chair of the Department of Pathology & Immunology since 2006. He received A.B., M.D., and Ph.D. degrees from Harvard University and trained in internal medicine at Brigham and Women’s Hospital in Boston and in infectious diseases at Barnes Hospital in St. Louis. He performed graduate work with Dr. Emil Unanue and postdoctoral studies with Dr. Bernard Fields. He is a member of the American Society for...

Live Traffic in St. Louis, MO